DrugPatentWatch Database Preview
Scilex Pharms Inc Company Profile
What is the competitive landscape for SCILEX PHARMS INC, and when can generic versions of SCILEX PHARMS INC drugs launch?
SCILEX PHARMS INC has one approved drug.
There are three US patents protecting SCILEX PHARMS INC drugs.
Summary for Scilex Pharms Inc
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Scilex Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scilex Pharms Inc | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | 9,925,264 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Scilex Pharms Inc | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | 9,931,403 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Scilex Pharms Inc | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Scilex Pharms Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Mexico | 349572 | ➤ Try a Free Trial |
| Canada | 2835595 | ➤ Try a Free Trial |
| Taiwan | 201249431 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
